Cargando…
Moving toward precision medicine with lung cancer organoids
In this issue of Cell Reports Medicine, Wang et al.(1) generated 160 human lung cancer organoids, primarily from malignant effusions, and tested their responses to clinically used drugs to determine whether the ex vivo organoid responses predicted patient responses.
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9975324/ https://www.ncbi.nlm.nih.gov/pubmed/36812886 http://dx.doi.org/10.1016/j.xcrm.2023.100952 |